Oxytocin
A nine-amino-acid neuropeptide synthesized in the hypothalamus and released by the posterior pituitary, studied across social bonding, uterine physiology, and CNS-behaviour research.
⏱ Half-Life
Short duration profile
Oxytocin demonstrates a short half-life characteristic in research literature, shaping how observation windows and study timelines are typically structured.
⚡ Onset Characteristics
Fast measurable response
Onset is observed as fast — a property that influences how researchers structure comparative studies versus other compounds in the signalling research category.
🧠 Key Notes
What makes it distinct
- 01Endogenous nonapeptide produced in the paraventricular nucleus
- 02Acts as both hormone and central neuromodulator
- 03Intranasal delivery common in behavioural research
🧬 Mechanism of Action
How it works
Oxytocin is synthesized in magnocellular neurons of the paraventricular and supraoptic hypothalamic nuclei, then transported to the posterior pituitary for systemic release. Peripherally it binds the oxytocin receptor (OXTR) on uterine smooth muscle and mammary myoepithelial cells, driving parturition contractions and milk ejection. Centrally, dendritically released oxytocin modulates amygdala, nucleus accumbens, and prefrontal circuitry — pathways implicated in pair-bonding, in-group trust, stress buffering, and social recognition. Intranasal delivery is the standard research route for CNS access.
✨ Documented Benefits
What the research shows it supports
🔍 Research Insights
What the literature shows
One of the most extensively studied neuropeptides in social neuroscience literature.
Effects are strongly context-dependent — enhances in-group trust while sometimes increasing out-group vigilance.
Intranasal bioavailability to the CNS remains an active methodological debate in the field.
🧪 Typical Research Use Cases
Where it appears in study design
Social bonding, trust, and affiliation research paradigms.
Stress and HPA-axis buffering studies.
Comparative behavioural research vs vasopressin analogs.
📚 References
Peer-reviewed literature
Primary research sources cited on this profile. All links resolve to PubMed or the publishing journal.
- [01]
Kosfeld, M. et al. (2005). Oxytocin increases trust in humans. Nature, 435(7042), 673–676.
Nature ↗ - [02]
Meyer-Lindenberg, A. et al. (2011). Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nature Reviews Neuroscience, 12(9), 524–538.
Nature Reviews Neuroscience ↗ - [03]
Neumann, I. D. & Landgraf, R. (2012). Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends in Neurosciences, 35(11), 649–659.
Trends in Neurosciences ↗ - [04]
Quintana, D. S. et al. (2021). Advances in the field of intranasal oxytocin research. Molecular Psychiatry, 26(1), 80–91.
Molecular Psychiatry ↗
⚠️ Not Medical Advice
Educational research summary only
This profile summarises published research on Oxytocin. It is not medical advice, diagnosis, or treatment, and it is not intended to promote human use, self-administration, or the substitution of professional healthcare. Discuss any health decision with a licensed clinician.
Continue Exploring
Also explore: PT-141, Selank, Kisspeptin